Showing results (161-170 of 482) with videos related to
Sort By:
Pageof 49
The Journal of Infectious Diseases|October 12, 2011
Antibody-dependent enhancement of Marburg virus infectionEri Nakayama, Daisuke Tomabechi, Keita Matsuno, et al.Journal of Virological Methods|November 25, 2010
Detection of all known filovirus species by reverse transcription-polymerase chain reaction using a primer set specific for the viral nucleoprotein geneHirohito Ogawa, Hiroko Miyamoto, Hideki Ebihara, et al.BMC Palliative Care|April 21, 2017
Family members of deceased palliative care patients receiving bereavement anniversary cards: a survey on the recipient's reactions and opinionsSwantje Goebel, Sandra Stephanie Mai, Christina Gerlach, et al.Journal of Virological Methods|March 21, 2007
Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigensSoraya Shahhosseini, Dipankar Das, Xiangguo Qiu, et al.Scientific Reports|April 19, 2013
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirinDarryl Falzarano, Emmie de Wit, Cynthia Martellaro, et al.Cells|June 2, 2021
Nipah Virus Efficiently Replicates in Human Smooth Muscle Cells without Cytopathic EffectBlair L DeBuysscher, Dana P Scott, Rebecca Rosenke, et al.Plos Neglected Tropical Diseases|April 18, 2015
A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa virusesDavid Safronetz, Chad Mire, Kyle Rosenke, et al.Antimicrobial Agents and Chemotherapy|July 17, 2013
Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndromeDavid Safronetz, Darryl Falzarano, Dana P Scott, et al.The Journal of Infectious Diseases|October 12, 2011
Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal Ebola virus infectionYoshimi Tsuda, David Safronetz, Kyle Brown, et al.Biorxiv : the Preprint Server for Biology|August 19, 2022
A replicon RNA vaccine induces durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have wanedMegan A Oâ Connor, David W Hawman, Kimberly Meade-White, et al.Pageof 49